RSS

Archive | FDA Drug Advisory RSS feed for this section

Heartburn Medications Linked to Kidney Damage

15. April 2016

Comments Off on Heartburn Medications Linked to Kidney Damage

Longterm usage of a typical kind of medication utilized to relieve heartburn, heartburn, and ulcers might result in an enhanced danger of kidney illness and kidney failure, brand-new research study programs. The research, released in the Journal of the American Society of Nephrology, contributes to previous research study that recommends proton-pump inhibitors (PPIs), a group […]

Continue reading...

Talc Tied to Fatal Ovarian Cancer

22. February 2016

Comments Off on Talc Tied to Fatal Ovarian Cancer

Jurors in St. Louis on Monday concluded J&J must pay $10 million in offsetting damages and $62 million in a penalty award to the household of Jackie Fox, who passed away of ovarian cancer in 2014 after utilizing Johnson’s talcum powder and another talc-based item for several years. It’s the very first time a jury […]

Continue reading...

Judge Will not Toss Birth Defect Zofran Cases

10. February 2016

Comments Off on Judge Will not Toss Birth Defect Zofran Cases

A Massachusetts federal judge on Friday (January 22, 2016) nixed GlaxoSmithKline PLC’s quote to dismiss all claims in multidistrict lawsuits declaring that the drug business’s “off-label” promo of its anti-nausea drug Zofran for early morning illness caused abnormality, stating that the quote appears to be early at finest. Among those researches exposed the exact same […]

Continue reading...

Infant Mortality linked to Agent Orange

7. February 2016

Comments Off on Infant Mortality linked to Agent Orange

“Since of AO’s (Agent Orange) possibly long half-life, ecological researches are likewise needed to figure out if AO has actually continued the Guamanian soil, and if present, research studies of the present population on Guam location had to figure out if AO remains to be a public health risk,” specifies the research authored by Jonathan […]

Continue reading...

Is Gastroschisis on the rise by a bad medication?

6. February 2016

Comments Off on Is Gastroschisis on the rise by a bad medication?

Coleen Boyle, director of the CDC’s National Center on Abnormality and Developmental Disabilities, stated it was immediate that scientists discover the reason for the problem and identify which females are at higher threat for having children with the condition. Over the 18 years preceeding 2012, the CDC has actually recorded a 263 % boost in […]

Continue reading...

Risk of Tramadol in children aged 17 years and younger

21. September 2015

Comments Off on Risk of Tramadol in children aged 17 years and younger

FDA is evaluating risks of using Tramadol in children aged 17 and younger Tramadol is not FDA-approved for use in children; however, data show it is being used “off-label” in the pediatric population. Health care professionals should be aware of this and consider prescribing alternative FDA-approved pain medicines for children. FDA is investigating the use […]

Continue reading...

Onglyza Linked to Pancreatic Cancer

10. September 2015

Comments Off on Onglyza Linked to Pancreatic Cancer

The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication, partly because it effectively controls blood sugar and does not encourage weight gain like other diabetes medications. The FDA has already recognized the link between Onglyza and a different health threat, heart failure. In April […]

Continue reading...

Opioid Increases risk of Neonatal Abstinence Syndrome

13. April 2015

Comments Off on Opioid Increases risk of Neonatal Abstinence Syndrome

Opioid pain use during pregnancy increases risk Of NSA (Neonatal Abstinence Syndrome) Researchers at Vanderbilt University Medical Center studied neonatal abstinence syndrome among infants after birth. The study examined just how commonly pregnant women are being prescribed opioids, that can increase the likelihood of Neonatal Abstinence Syndrome (NAS). The study authors looked at three years […]

Continue reading...

Zofran Lawsuit

4. March 2015

Comments Off on Zofran Lawsuit

Zofran Lawsuit Update Several medical studies have highlighted the risk of Zofran side effects, including cleft palate, cleft lip and congenital heart problems Cleft Lip Cleft Palate Heart Defects, including Atrial Septal Defect and Ventricular Septal Defect Hole In The Heart Congenital heart defect Atrial septal defect Ventricular septal defect Tetralogy of Fallot Fetal death In […]

Continue reading...

Zofran Birth Defect Warning

21. February 2015

Comments Off on Zofran Birth Defect Warning

Attention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has issued an updated warning against Ondansetran, better known by its brand name, Zofran, use in pregnancy discussed in OBGYN News. Zofran is a 5-HT3 receptor antagonist approved by the FDA for preventing nausea and vomiting […]

Continue reading...